The Career Enhancement Core (CEC) will oversee the educational and career enhancement activities of the UCDC. The overarching goal of the CEC is to train the next-generation of rare diseases researchers. The main aim of the CEC is to recruit, train, and retain trainees and faculty at different career stages and provide resources to facilitate a career in rare diseases research, specifically in urea cycle disorders (UCD) and other inborn errors of metabolism. Additionally, the CEC will also build on its previous accomplishments and enhance a curriculum that will be beneficial for career enhancement of early-stage investigators not only in the UCDC, but across all other consortia of the RDCRN. CEC Program Overview, Application, Review, and Selection Process The CEC has predoctoral and postdoctoral/junior faculty components. The predoctoral component focuses on clinical and research training of medical students, graduate students, genetic counselors, and neuropsychology trainees by didactics and involvement in data-mining and clinical projects of the UCDC. Postdoctoral and junior faculty career enhancement will focus on funding protected research time, mentoring on a specific UCD research project, and assisting in the transition to an independent research career. Applications will consist of a 5-page research proposal, statement of relevance of proposal to UCDC mission, career development plan, and letters of support from the mentor and the sponsoring Institution. Applications will be scored using NIH scoring system by a ?study section? consisting of the CEC leadership, UCDC investigators and NIH PO/SO. The award will be for one year; depending upon the progress and the impact of the work, trainees will be considered for a second year of funding. Special focus will be paid to recruit women and individuals from underrepresented minorities. Oversight and Evaluation The accomplishments of the specific aims of the candidate will be monitored frequently so that any barriers or difficulties, whether programmatic or personal, can be identified and addressed early. The progress of the trainee will be assessed by primary research mentor, presentations at the monthly UCDC phone meetings, and quarterly meetings with the CEC PI (Dr. Nagamani). Awardees present at the annual UCDC conference and submit a written progress report at the end of the funding. Through the activities of the CEC, the UCDC hopes to build on its already outstanding record of training successful next-generation of researchers in rare diseases.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54HD061221-17
Application #
10018960
Study Section
Special Emphasis Panel (ZTR1)
Project Start
2003-09-30
Project End
2024-07-31
Budget Start
2020-08-01
Budget End
2021-07-31
Support Year
17
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Children's Research Institute
Department
Type
DUNS #
143983562
City
Washington
State
DC
Country
United States
Zip Code
20010
Kho, Jordan; Tian, Xiaoyu; Wong, Wing-Tak et al. (2018) Argininosuccinate Lyase Deficiency Causes an Endothelial-Dependent Form of Hypertension. Am J Hum Genet 103:276-287
Posset, Roland; Garbade, Sven F; Boy, Nikolas et al. (2018) Transatlantic combined and comparative data analysis of 1095 patients with urea cycle disorders-a successful strategy for clinical research of rare diseases. J Inherit Metab Dis :
Nagamani, Sandesh C S; Agarwal, Umang; Tam, Allison et al. (2018) A randomized trial to study the comparative efficacy of phenylbutyrate and benzoate on nitrogen excretion and ureagenesis in healthy volunteers. Genet Med 20:708-716
Sin, Yuan Yan; Ballantyne, Laurel L; Richmond, Christopher R et al. (2018) Transplantation of Gene-Edited Hepatocyte-like Cells Modestly Improves Survival of Arginase-1-Deficient Mice. Mol Ther Nucleic Acids 10:122-130
Uittenbogaard, Martine; Brantner, Christine A; Chiaramello, Anne (2018) Epigenetic modifiers promote mitochondrial biogenesis and oxidative metabolism leading to enhanced differentiation of neuroprogenitor cells. Cell Death Dis 9:360
Uittenbogaard, Martine; Brantner, Christine A; Fang, ZiShui et al. (2018) Novel insights into the functional metabolic impact of an apparent de novo m.8993T>G variant in the MT-ATP6 gene associated with maternally inherited form of Leigh Syndrome. Mol Genet Metab 124:71-81
Waisbren, Susan E; Cuthbertson, David; Burgard, Peter et al. (2018) Biochemical markers and neuropsychological functioning in distal urea cycle disorders. J Inherit Metab Dis 41:657-667
Sin, Yuan Yan; Price, Phillipe R; Ballantyne, Laurel L et al. (2017) Proof-of-Concept Gene Editing for the Murine Model of Inducible Arginase-1 Deficiency. Sci Rep 7:2585
Krivitzky, Lauren S; Walsh, Karin S; Fisher, Evelyn L et al. (2016) Executive functioning profiles from the BRIEF across pediatric medical disorders: Age and diagnosis factors. Child Neuropsychol 22:870-88
Laemmle, Alexander; Gallagher, Renata C; Keogh, Adrian et al. (2016) Frequency and Pathophysiology of Acute Liver Failure in Ornithine Transcarbamylase Deficiency (OTCD). PLoS One 11:e0153358

Showing the most recent 10 out of 113 publications